Medidata Solutions announced that Sanofi has selected Medidata's targeted source document verification solution
Medidata Solutions announced that Sanofi has selected Medidata's targeted source document verification solution—Medidata Rave TSDV—to support its risk-based monitoring initiatives for its clinical operations and data managements teams. This builds upon Sanofi's adoption of Medidata's cloud-based solutions for electronic data capture and management (EDC), safety data collection, medical coding, clinical business analytics and industry benchmarks, which were implemented in 2012.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.